mTOR regulates memory CD8 T-cell differentiation

Nature

Volumn 460, Issue 7251, 2009, Pages 108-112

  Araki, Koichi ^a   Turner, Alexandra P ^b   Shaffer, Virginia Oliva ^b   Gangappa, Shivaprakash ^b   Keller, Susanne A ^b   Bachmann, Martin F ^c   Larsen, Christian P ^c   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CELL PROTEIN; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BCL 2; PROTEIN FKBP12; RAPAMYCIN; RAPTOR PROTEIN; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

CYTOLOGY; IMMUNITY; IMMUNIZATION; MEMORY; RODENT; VACCINE; VIRUS;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; EFFECTOR CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO GENE TRANSFER; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHESUS MONKEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS LIKE AGENT; VIRUS MENINGITIS;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACACA MULATTA; MICE; MICE, INBRED C57BL; PROTEIN KINASES; SIROLIMUS; TRANSCRIPTION FACTORS;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAMMALIA; MUS; PRIMATES; RAPTORES; VACCINIA VIRUS ANKARA;

EID: 67650074206     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08155     Document Type: Article

References (24)

1. Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171-192 (2007).
2. Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848-862 (2008).
3. Klebanoff, C. A., Gattinoni, L. & Restifo, N. P. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol. Rev. 211, 214-224 (2006).
4. Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nature Rev. Immunol. 8, 247-258 (2008).
5. Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
6. Cao, W. et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nature Immunol. 9, 1157-1164 (2008).
7. Sinclair, L. V. et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunol. 9, 513-521 (2008).
8. Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797-7802 (2008).
9. Haxhinasto, S., Mathis, D. & Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4 + Foxp3+ cells. J. Exp. Med. 205, 565-574 (2008).
10. Kaech,S. M. et al. Selective expression oftheinterleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol. 4, 1191-1198 (2003).
11. Huster, K. M. et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cel subsets. Proc. Natl Acad. Sci. USA 101, 5610-5615 (2004).
12. Schluns, K. S., Kieper, W. C., Jameson, S. C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 1, 426-432 (2000).
13. Tan, J. T. et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD41 cells. J. Exp. Med. 195, 1523-1532 (2002).
14. Wherry,E.J.et al.Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225-234 (2003).
15. Sarkar,S. et al. Functional and genomic profiling of effector CD8 Tcell subsets with distinct memory fates. J. Exp. Med. 205, 625-640 (2008).
16. Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007).
17. Grayson, J. M., Zajac, A. J., Altman, J. D. & Ahmed, R. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164, 3950-3954 (2000).
18. Storni,T.et al. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172, 1777-1785 (2004).
19. Ohtani,M.et al. Mammalian target of rapamycin and glycogen synthasekinase3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112, 635-643 (2008).
20. Weichhart, T. et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29, 565-577 (2008).
21. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
22. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
23. Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD8(+) T cell differentiation during viral infection. Immunity 27, 393-405 (2007).
24. Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 (1998).